BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6544205)

  • 1. [Combined medication of nitroprusside and dopamine or dobutamine in acute heart failure].
    Ye JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):252-4. PubMed ID: 6544205
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
    Pomer S; Elert O; Sarai K; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):77-81. PubMed ID: 3957495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiologic basis for combined nitroprusside-dopamine therapy in post-myocardial infarction heart failure.
    Dracup KA; Breu CS; Tillisch JH
    Heart Lung; 1981; 10(1):114-20. PubMed ID: 6905821
    [No Abstract]   [Full Text] [Related]  

  • 4. Calculations for dopamine, dobutamine and nitroprusside dosages.
    Nappi JM
    Am J Hosp Pharm; 1979 Jul; 36(7):881, 887. PubMed ID: 474577
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined infusion of nitroprusside and dobutamine in the treatment of severe congestive heart failure (author's transl)].
    Cyran J; Bolte HD
    Klin Wochenschr; 1979 Sep; 57(17):883-91. PubMed ID: 502356
    [No Abstract]   [Full Text] [Related]  

  • 6. Dobutamine in heart failure.
    Chatterjee K; Bendersky R; Parmley WW
    Eur Heart J; 1982 Dec; 3 Suppl D():107-14. PubMed ID: 6761125
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of a sodium nitroprusside-dobutamine combination in left cardiac failure].
    Moore N; Champoud O; Berland J; Cribier A; Letac B
    Therapie; 1985; 40(2):99-103. PubMed ID: 4002197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined high doses of dopamine and nitroprusside in the treatment of cardiogenic shock].
    Jakobsen CJ; Grabe N
    Ugeskr Laeger; 1984 Aug; 146(35):2628-9. PubMed ID: 6515876
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our experience with the treatment of cardiogenic shock in recent myocardial infarction with dopamine and sodium nitroprusside].
    Korewicki J; Ostrzycki A; Opolski G
    Kardiol Pol; 1984; 27(5):345-51. PubMed ID: 6387246
    [No Abstract]   [Full Text] [Related]  

  • 10. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
    Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of sodium nitroprusside in congestive heart failure (author's transl)].
    Tao SC; Liu LS; Wang LL; Ge H; Yao KB
    Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(3):178-82. PubMed ID: 553004
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic equivalence of automated nitroglycerin- and nitroprusside-infusions combined with dobutamine for augmentation of cardiac output in patients following aorta coronary bypass-operation.
    Pomer S; Sarai K; Krause E; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):602-7. PubMed ID: 6437993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Catecholamines use in patients with heart failure].
    Iino K; Ito H
    Nihon Rinsho; 2007 May; 65 Suppl 5():30-3. PubMed ID: 17571362
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic effect of unloading therapy in acute myocardial infarction with congestive heart failure].
    Kobayashi A; Hiramatsu S; Katoh Y; Muramatsu J; Kikawada R
    Kokyu To Junkan; 1987 Oct; 35(10):1071-7. PubMed ID: 3122295
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simplified preparation of sodium nitroprusside for intravenous use (author's transl)].
    Zheng WX
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Sep; 8(3):238-9. PubMed ID: 7307957
    [No Abstract]   [Full Text] [Related]  

  • 17. A circulatory model for combined nitroprusside-dopamine therapy in acute heart failure.
    Yu C; Roy RJ; Kaufman H
    Med Prog Technol; 1990 May; 16(1-2):77-88. PubMed ID: 2138700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative enhancement of left ventricular performance by combined inotropic-vasodilator therapy with preload control.
    Miller DC; Stinson EB; Oyer PE; Derby GC; Reitz BA; Shumway NE
    Surgery; 1980 Jul; 88(1):108-17. PubMed ID: 7385014
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of intravenous amrinone (Win 40680) on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine].
    Tanaka K; Takano T; Shimai S; Takada K; Koh M; Seino Y; Katoh T; Nejima J; Munakata K; Hayakawa H
    Kokyu To Junkan; 1986 Jun; 34(6):651-7. PubMed ID: 3764113
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
    Dei Cas L; Giunti G; Faggiano P; Fappani A; Ferrari R; La Canna G; Riva S; Zanini R
    Cardiologia; 1985 Mar; 30(3):205-11. PubMed ID: 4064071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.